Novel Multitarget Drug Development Strategies to Combat Neurodegeneration
Sperlagh, B, Baranyi, M, Goloncser, F, Kulcsar, Sz, Matyus, P, Khoo, M.L, Huleatt, P, Chai, C.LL
Published in Digestive diseases and sciences (23.05.2022)
Published in Digestive diseases and sciences (23.05.2022)
Get full text
Journal Article
Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral Activity
Fattorusso, Caterina, Gemma, Sandra, Butini, Stefania, Huleatt, Paul, Catalanotti, Bruno, Persico, Marco, De Angelis, Meri, Fiorini, Isabella, Nacci, Vito, Ramunno, Anna, Rodriquez, Manuela, Greco, Giovanni, Novellino, Ettore, Bergamini, Alberto, Marini, Stefano, Coletta, Massimo, Maga, Giovanni, Spadari, Silvio, Campiani, Giuseppe
Published in Journal of medicinal chemistry (17.11.2005)
Published in Journal of medicinal chemistry (17.11.2005)
Get full text
Journal Article
Scabrosin esters and derivatives: chemical derivatization studies and biological evaluation
Chai, Christina L.L., Elix, John A., Huleatt, Paul B., Waring, Paul
Published in Bioorganic & medicinal chemistry (15.11.2004)
Published in Bioorganic & medicinal chemistry (15.11.2004)
Get full text
Journal Article
The first electrochemical study of epidithiopiperazine-2,5-diones, a special class of α,α′-disulfide bridged cyclic dipeptides
Chai, Christina L. L., Heath, Graham A., Huleatt, Paul B., O’Shea, Gavin A.
Published in Journal of the Chemical Society, Perkin Transactions 2 (1999)
Published in Journal of the Chemical Society, Perkin Transactions 2 (1999)
Get full text
Journal Article